HomeELIC • STO
add
Elicera Therapeutics AB
Previous close
kr 2.39
Day range
kr 2.39 - kr 2.47
Year range
kr 0.85 - kr 3.53
Market cap
83.87M SEK
Avg Volume
506.57K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.87M | 10,266.56% |
Operating expense | 5.78M | 10.31% |
Net income | -2.60M | 45.19% |
Net profit margin | -90.68 | 99.47% |
Earnings per share | — | — |
EBITDA | -2.91M | 44.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.40M | -10.16% |
Total assets | 27.56M | -8.67% |
Total liabilities | 6.79M | -50.70% |
Total equity | 20.77M | — |
Shares outstanding | 35.09M | — |
Price to book | 4.05 | — |
Return on assets | -24.81% | — |
Return on capital | -32.98% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.60M | 45.19% |
Cash from operations | -4.23M | -220.81% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -4.23M | -220.84% |
Free cash flow | -3.45M | -169.22% |
About
Founded
2014
Website
Employees
2
